Showing results (581-590 of 661) with videos related to
Sort By:
Pageof 67
JCO Precision Oncology|March 9, 2022
Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid TumorsPashtoon M Kasi, Gordon Fehringer, Hiroya Taniguchi, et al.Annals of Hematology|February 3, 2026
Efficacy and safety of epcoritamab in relapsed or refractory large B-cell lymphoma: 3-year update from the EPCORE NHL-1 trialYasmin H Karimi, Chan Y Cheah, Michael Roost Clausen, et al.The Lancet. Gastroenterology & Hepatology|September 10, 2021
Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelinesGlenn K Bonney, Claire Alexandra Chew, Peter Lodge, et al.Annals of Surgical Oncology|September 4, 2012
A RAND/UCLA appropriateness study of the management of familial gastric cancerMatthew Dixon, Rajini Seevaratnam, Debrah Wirtzfeld, et al.The New England Journal of Medicine|September 13, 2013
Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancerJean-Yves Douillard, Kelly S Oliner, Salvatore Siena, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAActSheela Rao, Francesco Sclafani, Cathy Eng, et al.Journal of the National Cancer Institute|September 26, 2015
A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal CancerFrancesco Sclafani, Tae Y Kim, David Cunningham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2008
Potential regional differences for the tolerability profiles of fluoropyrimidinesDaniel G Haller, Jim Cassidy, Stephen J Clarke, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 25, 2015
International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancerKyoichi Takaori, Claudio Bassi, Andrew Biankin, et al.Oncogene|June 1, 2019
Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancerSteve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.Pageof 67